citroma

Manufacturer
Cariba International | Vi-Jon, LLC
Effective date
2022-05-03
Label type
HUMAN OTC DRUG LABEL
Version
10
Source
legacy-cache
Hydrated at
2026-08-01 22:02:06

Label at a glance#

Productcitroma
Active ingredientMAGNESIUM CITRATE
Label structure14 sections

Dosage and administration

drink a full glass (8 ounces) of liquid with each dose may be taken as a single dose or in divided doses Adults and children 12 years and over - 6.5 to 10 fl oz maximum 10 fl oz in 24 hours children 6 to under 12 years of age - 3 to 7 fl oz maximum 7 fl oz in 24 hours children 2 to under 6 years of age - 2 to 3 fl oz maximum 3 fl oz in 24 hours children under 2 years of age - ask a doctor discard unused product wi...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Magnesium citrate 1.745 g per fl oz

Purpose

OTC - PURPOSE SECTION

Saline Laxative

Use

INDICATIONS & USAGE SECTION

for relief of occasional constipation (irregularity).  Generally productes bowel movement in 1/2 to 6 hours.

Warnings

WARNINGS SECTION

for this product

Ask a doctor before use

OTC - ASK DOCTOR SECTION

If you have

  • kidney disease
  • a magnesium or potassium-restricted diet
  • abdominal pain, nausea, or vomiting
  • noticed a sudden change in bowel habits that persists over a period of 2 weeks
  • already used a laxative for a period longer than 1 week.

Ask a doctor or pharmacist before use

OTC - ASK DOCTOR/PHARMACIST SECTION

If you are taking any other drug.  Take this product 2 or more hours before or after other durgs.  Laxatives may affect how other durgs work.

Stop use and ask a doctor

OTC - STOP USE SECTION

If you have rectal bleeding or failure to have a bowel movement after use.  These could be signs of serious condition.

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • drink a full glass (8 ounces) of liquid with each dose
  • may be taken as a single dose or in divided doses

Adults and children 12 years and over - 6.5 to 10 fl oz maximum 10 fl oz in 24 hours

children 6 to under 12 years of age - 3 to 7 fl oz maximum 7 fl oz in 24 hours

children 2 to under 6 years of age - 2 to 3 fl oz maximum 3 fl oz in 24 hours

children under 2 years of age - ask a doctor

discard unused product within 24 hours of opening bottle

Other information

SPL UNCLASSIFIED SECTION

  • each fl oz contains: magnesium 290 mg
  • each fl oz contains: potassium 80 mg

inactive ingredients

INACTIVE INGREDIENT SECTION

citric acid, lemon oil, potassium bicarbonate, water purified, sodium saccharin

Adverse reactions

ADVERSE REACTIONS SECTION

Distributed by:

Cariba International

P.O. Box 1208

Safety Harbor, Florida 34695

MADE IN USA WITH US AND FOREIGN COMPONENTS

Principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CARIBA

MAGNESIUM CITRATE

SALINE LAXATIVE

ORAL SOUTION

PLEASING LEMONY FLAVOR

PASTEURIZED

VERH LOW SODIUM

DO NOT USE IF TAMPER EVIDENT TWST-OFF CAP IS MISSING, BROKEN OR SEPRATED FROM NECKRING

10 FL OZ (296 mL)

image descriptionimage description

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
67860-68667860-686-38

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5b86fd1d-dbfc-4532-ae6d-0b82a0708472ed52376a-2f9f-49a0-8bf2-b1bb6fc18b862022-09-16Warnings, Adverse reactionsExact identifier
spl set id: ed52376a-2f9f-49a0-8bf2-b1bb6fc18b86

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.